The expression levels of both NF-κB and its phosphorylated p65 subunit were evaluated by Western blotting analysis in both RA patients and HS LPS-stimulated PBMCs alone or after 48 h of treatment with 10 μg/mL of PE-EVOOs. This evidence concerns the gene NFKB1 and rheumatoid arthritis.